Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Study Evaluating Well-being/Quality of Life in Schizophrenic Patients Treated With Seroquel XR® (Quetiapine) and Other Atypical Antipsychotics.A 9-month, Observational, Multicentric Prospective Study.

NCT00689325 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00689325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00689325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Study Evaluating Well-being/Quality of Life in Schizophrenic Patients Treated With Seroquel XR® (Quetiapine) and Other Atypical Antipsychotics.A 9-month, Observational, Multicentric Prospective Study.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2008
Completion date
January 31, 2010
Enrollment
158 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia